Cagrilintide's C20 fatty-diacid modification extends half-life to ~7 days, making it viable for once-weekly dosing alongside semaglutide or tirzepatide
The active factor turned out to be a small tripeptide that tightly bound copper
+ The calculations use standard pharmaceutical formulas: concentration (mg/mL) = vial size water volume, and draw volume (mL) = target dose concentration
The lack of well-designed, comprehensive, human clinical studies means that there is little to no reliable scientific evidence to support the safety or effectiveness of BPC-157 in humans. A measure in the Defense authorization bill that passed the House would remove legally-available peptides from the DoDs prohibited substances list
| Body Protection Compound-157 (BPC-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice, attracting growing interest in regenerative medicine for tendon and ligament repair
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial